Description
Bellast Prime Ultra with Lidocaine is a CE-marked dermal filler from the Bellast Prime range by Fox Pharma. It is formulated with 24 mg/mL cross-linked hyaluronic acid (HA) and includes 0.3% lidocaine to improve injection comfort. The product is designed for deep structural augmentation, with the filler intended for injection into the subcutaneous tissue (beneath the dermis) to provide lift, volume restoration, and define facial contours. Indications typically include facial contouring (chin, cheeks, jawline), nasal augmentation, and volumising in areas requiring substantial structural support.
What Bellast Prime Ultra Is Similar To
Bellast Prime Ultra performs similarly to other high-viscosity, deep-placement HA fillers used for facial contouring and non-surgical rhinoplasty. For example, compared with lighter HA fillers (designed for superficial wrinkles or hydration), Bellast Prime Ultra resembles the performance profile of dense fillers used for chin, jaw, or nose augmentation. It differs from lighter fillers (e.g., those for fine lines or periorbital areas) by offering greater structural support and lift. Compared with a filler such as Profhilo (which primarily hydrates and improves skin quality), Bellast Prime Ultra focuses on volume and contour rather than superficial skin texture. This comparison is provided for clinical orientation only and does not imply interchangeability.
Treatment Areas / Indications
According to the manufacturer’s product page, Bellast Prime Ultra is intended for:
-
Nose (nasal augmentation)
-
Chin
-
Cheeks
-
Jaw / jawline
If additional treatment areas are required (e.g., mid-face, cheeks, other zones), they are not specified in the publicly available documentation.
Usage / Administration (IFU-only)
-
Injection depth: subcutaneous tissue (below dermis)
-
Needle gauge (included): 25G needle and 27G needle supplied in the kit.
-
Volume per point / injection site: not provided by manufacturer.
-
Frequency / number of sessions: not provided by manufacturer.
-
Professional-use disclaimer: To be administered only by qualified medical professionals under aseptic conditions. (As standard for CE-marked dermal fillers.)
Some practitioners may use cannula or layering techniques for deep-tissue fillers; this is not included in the official manufacturer instructions for Bellast Prime Ultra.
Ingredient List
-
Hyaluronic acid (cross-linked) — 24 mg/mL
-
Lidocaine — 0.3%
-
Excipients / gel matrix / buffer — not specified in publicly available documentation
Presentation & Longevity
-
Packaging: 1 × 1.0 ml prefilled syringe, supplied with 1 × 25G needle and 1 × 27G needle.
-
Shelf life / expiry: not provided by manufacturer in publicly accessible sources.
-
Expected duration of effect: 6–12 months.
Safety Notes / Contraindications
According to the manufacturer:
-
Not to be used in patients with bleeding disorders or those on medications affecting platelet function.
-
Not to be resterilised or mixed with other products before injection.
-
Contraindicated in patients with known lidocaine allergy.
-
Not to be used in areas with active inflammation, infection, or other active dermal disease.
-
Not recommended for patients prone to keloid formation.
-
Not advised for use in pregnant or breastfeeding patients.
Standard precautionary statement (if not otherwise specified): Use is contraindicated in patients with known hypersensitivity to any component or with active skin infections at the injection site. Treatments should only be performed by certified medical professionals.
Regulatory Status
-
CE-marked medical device.
-
UKCA status: not explicitly stated — practitioners should verify relevant regulatory labeling on the product packaging or IFU at time of purchase.
FAQ
Q1: What is the mechanism of action of Bellast Prime Ultra?
A1: Bellast Prime Ultra is a hyaluronic-acid (HA) dermal filler whose cross-linked HA gel is injected into the subcutaneous layer beneath the skin. Once placed, the gel provides volume and structural support, restoring facial contours and lift. Over time, the body gradually degrades the HA by endogenous hyaluronidases, making the filler bio-absorbable.
Q2: How long do the results of Bellast Prime Ultra typically last?
A2: The manufacturer states that clinical effects of Bellast Prime Ultra generally persist for 6 to 12 months. Longevity can vary depending on patient factors, injection technique, and treated area.
Q3: Is the injection painful?
A3: Bellast Prime Ultra includes 0.3% lidocaine, a local anaesthetic, which helps to minimise discomfort during injection. As with all injectable treatments, some patients may still experience mild stinging, pressure, or temporary discomfort during and after the procedure — but pain is generally mitigated by the lidocaine.
Q4: Can Bellast Prime Ultra be used for superficial wrinkles or fine lines?
A4: No — according to the manufacturer, Bellast Prime Ultra is formulated for deep structural enhancement (subcutaneous tissue), not superficial dermal correction. For fine lines or superficial wrinkles, lighter products in the same range (e.g., fillers designed for upper dermis) are more appropriate.
Q5: Who should perform the injections with Bellast Prime Ultra?
A5: Injection must be performed only by qualified and trained medical professionals under strictly aseptic conditions, using the supplied sterile needles (25G or 27G). The manufacturer does not provide guidance for self-administration.
